GlassScriptPrepare for your visit
Suzanne Alkul
MOHS-Micrographic Surgery · Houston, TX · NPI 1245723543
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$1,141.19
in general payments reported to CMS, 2019-2025 · $326 in 2025
The $326 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Who reported paying
General payments only, top 6 by amount.
- Journey Medical Corporation $250.01
- Abbvie INC. $232.48
- E.R. Squibb & Sons, L.L.C. $134.73
- Janssen Biotech, INC. $112.11
- Novartis Pharmaceuticals Corporation $110.09
- Incyte Corporation $88.30
Drugs and devices associated with these payments
Skyrizi Rinvoq Opzelura Simponi Aria Simponi Stelara Tremfya Innovamatrix Ac Dupixent Kerecis Omega3 Surgiclose Remicade Taltz
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Suzanne Alkul listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/11390785/suzanne-alkul